Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer, and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.

Quotes for Respiratorius AB

Right Now

+/-
%
0,00%
Latest
High
Low
Volume
0
Turnover (SEK)
0
Market Value (MSEK)
24,7
Time (Latest trade)

Board

CEO

  • Johan Drott

Chairperson of the Board

  • Karin Wehlin

Board

  • Johan Drott
  • Kristina Drott
  • Mia Lundblad

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 8,57 8,57 2024-09-26
Valcuria Holding AB 3,61 3,61 2024-09-26
Hans Mandahl 1,96 1,96 2024-09-26
Fenja Capital Partners A/S 1,84 1,84 2024-09-26
Hartmut Wiese 1,45 1,45 2024-09-26
Göran Lennart Rehn 1,37 1,37 2024-09-26
Nicholas Peebo 1,10 1,10 2024-09-26
Hans Harvig 0,99 0,99 2024-09-26
Mattias Nilsson 0,95 0,95 2024-09-26
Ulf Stahlin 0,94 0,94 2024-09-26
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

*Compiled data from Millistream